demonstrated that two different mechanisms can contribute to a robust anti-tumor response induced by anti-4-1BB antibodies in certain models and contexts; 1) stimulating the effector T cells and 2) depleting T regulatory (Treg) cells. Here, TNFRSF9 is linked to neoplasm.